Acelyrin Inc (SLRN)
3.14
-0.08
(-2.48%)
USD |
NASDAQ |
Dec 20, 16:00
3.145
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Shareholders Equity (Quarterly): 528.28M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Bristol-Myers Squibb Co | 17.14B |
| Biomarin Pharmaceutical Inc | 5.413B |
| Lexicon Pharmaceuticals Inc | 178.51M |
| Arbutus Biopharma Corp | 106.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 618.31M |
| Total Liabilities (Quarterly) | 90.03M |